---
title: "Low dose naltrexone - Chronic pain"
sidebar: mydoc_sidebar
permalink: db00704-mesh-d059350-1.html
toc: false 
---


Path ID: `DB00704_MESH_D059350_1`
{% include image.html url="images/db00704-mesh-d059350-1.png" file="db00704-mesh-d059350-1.png" alt="db00704-mesh-d059350-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D009270 | Low Dose Naltrexone | Drug |
| UniProt:O00206 | Toll-like receptor 4 | Protein |
| UniProt:P01375 | Tumor necrosis factor | Protein |
| GO:0006954 | Inflammatory response | BiologicalProcess |
| MESH:D059350 | Chronic pain | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Low Dose Naltrexone | DECREASES ACTIVITY OF | Toll-Like Receptor 4 |
| Toll-Like Receptor 4 | INCREASES ACTIVITY OF | Tumor Necrosis Factor |
| Tumor Necrosis Factor | POSITIVELY REGULATES | Inflammatory Response |
| Inflammatory Response | POSITIVELY CORRELATED WITH | Chronic Pain |
|---------|-----------|---------|

Comment: It seems that only low doses of naltrexone has been documented to enhance or produce an analgesic response. Low-dose naltrexone (LDN) describes the off-label use of naltrexone at low doses for diseases not related to chemical dependency or intoxication. The annotation is for Low Dose Naltrexone (LDN).

Reference: [https://go.drugbank.com/drugs/DB00704#mechanism-of-action](https://go.drugbank.com/drugs/DB00704#mechanism-of-action){:target="_blank"}